PCI Synthesis Overview
- Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
150
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
1
PCI Synthesis General Information
Description
Manufacturer of small molecule drug substance and other specialty chemical products. The company offers a wide range of services, including process research and early-stage development as well as commercial production of new chemical entities, generic active pharmaceutical ingredients and other specialty chemical products, providing pharmaceutical and medical device industries with drugs delivery at a competitive price.
Contact Information
Website
www.pcisynthesis.com
Formerly Known As
Polycarbon Industries Inc., Polycarbon Industries Incorporated
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Office
- 9 Opportunity Way
- Newburyport, MA 01950
- United States
+1 (978) 000-0000
PCI Synthesis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PCI Synthesis Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer of small molecule drug substance and other specialty chemical products. The company offers a wide range of
Multi-line Chemicals
Newburyport, MA
150
As of 2018
000000000000
00000
laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
000000000000000
Sao Paulo, Brazil
000000
it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
000000000000000
Plankstadt, Germany
0000
As of 0000
000000000000
Add Comparison
PCI Synthesis Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bayer (Brazil) | Corporation | Sao Paulo, Brazil | ||||
| 000000000000 | Private Equity-Backed | Plankstadt, Germany | 0000 | 000000000000 | ||
| 00000000 00000000 | Corporate Backed or Acquired | College Station, TX | 0000 | 0000000000 | ||
| 000000 (0000000000 | Formerly VC-backed | San Diego, CA | 00 | 00.00 | 000000&0 | 00.00 |
| 000000 | Private Equity-Backed | Clearwater, FL | 000 | 0000 | 000000 - 000 |
PCI Synthesis Patents
PCI Synthesis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3728178-A4 | Synthesis of azelaic acid | Inactive | 22-Dec-2017 | 000000000 | 0 |
| EP-3728178-A1 | Synthesis of azelaic acid | Inactive | 22-Dec-2017 | 000000000 | |
| US-10358408-B2 | Synthesis of azelaic acid | Active | 22-Dec-2017 | 000000000 | 00 |
| US-20190194115-A1 | Synthesis of azelaic acid | Active | 22-Dec-2017 | 000000000 | |
| CA-3086530-A1 | Synthesis of azelaic acid | Pending | 22-Dec-2017 | C07C51/38 |
PCI Synthesis Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Edward Price | Founder, President & Chief Executive Officer | ||
| Paul Sulloway | Chief Financial Officer, Finance & Chief Operating Officer, Operations |
PCI Synthesis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PCI Synthesis Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 00 | 23-Aug-2005 | 0000000000 | Industrial Chemicals | 000000 00 |